Clinical characteristics and prognosis of hepatoid adenocarcinoma of the stomach.
- Author:
Lutian YAO
1
;
Huimian XU
Author Information
1. Department of Surgical Oncology, The First Hospital of China Medical University, Shenyang 110001, China. xuhuimian@126.com.
- Publication Type:Journal Article
- MeSH:
Adenocarcinoma;
Humans;
Liver Neoplasms;
secondary;
Neoplasm Recurrence, Local;
Prognosis;
Stomach Neoplasms;
pathology;
alpha-Fetoproteins
- From:
Chinese Journal of Gastrointestinal Surgery
2014;17(2):196-200
- CountryChina
- Language:Chinese
-
Abstract:
Hepatoid adenocarcinoma of the stomach (HAS) is a special type of gastric cancer characterized with hepatoid differentiation and the production of large amounts of α-fetoprotein (AFP). The pathogenesis of HAS is still not clear. Most of the relative studies are single case reports, and studies with large sample are absent. The prognosis of HAS is poor. HAS has a high rate of liver metastasis. The biology behaviors of HAS differ from common gastric cancers. Radical resection of the gastric cancer is considered to be the main treatment when no liver metastasis is found, while the treatment regimens of the metastasis lesions are still in debate. The serum AFP test is important for the early detection and diagnosis of HAS, and it is crucial for monitoring the therapeutic effect and the relapse and metastasis of the tumor.
